baber/WOPTO huggingface dataset:
Patent NZ-527179-A (NZ)
Title: Hydrogen fueled reciprocating spark ignition engine
Inventor: THIES JOSEPH ROBERT
IPC: F02D41/02
Filed: 2003-07-24
Abstract: A hydrogen fueled reciprocating spark ignition engine is disclosed, wherein it comprises: a fuel system for providing gaseous hydrogen to the cylinders of the engine and a lean Nox trap coupled to the engine for treating the exhaust from the engine; an EGR system for providing recirculated exhaust gas to the engine: and a controller for operating the fuel system and the EGR system during periodic purging of the lean Nox trap such that the engine is operated at a richer than stoichiometric air/fuel ratio, and with the mass of EGR approximating 40-80% of the mass of air and fuel. The hydrogen fueled reciprocating spark ignition engine may also include a three way catalyst mounted upstream of the lean Nox trap and a selective catalytic reduction (SCR) converted mounted downstream from the lean Nox catalyst.
Patent NZ-527237-A (NZ)
Title: Sliding keel sailboat with a hull with reduced rolling
Inventor: FERRARI AGOSTINO
IPC: B63B15/00
Filed: 2001-07-30
Abstract: The present invention refers to a sliding keel sailboat of the type comprising a sailing hull, a mast and a sailing arrangement whereon aero-dynamic forces, apt to be transferred to the hull through said mast, push, said mast being integral with a pivoting structure which can swing around a pivoting axis, parallel to a longitudinal central axis of the sailboat, in a respective seat in the sailing hull, said pivoting structure being arranged so that the crew can stand on it so as to balance said forces acting on the mast.
Patent NZ-530497-A (NZ)
Title: System and method for payment using radio frequency identification in contact and contactless transactions
Inventor: BERARDI MICHAEL J
IPC: G06Q20/00
Filed: 2002-07-10
Abstract: A transponder-reader payment system includes a fob 102 including a transponder 114, and a RFID reader 104 for interrogating the transponder. The system may further include a personalization system for populating onto the fob and RFID reader identifying information and security and authentication keys which may be used during mutual authentication of the fob and the reader and for completing a transaction. In exemplary operation, the fob and RFID reader may be personalized, the fob may be presented to the RFID reader for interrogation, the fob and reader may engage in mutual authentication, and fob identifying information may be provided to the reader for transaction completion. In another exemplary embodiment, operation of the transponder-reader payment system may be controlled by an activation circuit. Further, the fob may be responsive to multiple interrogation signals.
Patent NZ-531846-A (NZ)
Title: TNF-alpha inhibitors and their preparation and pharmaceutical compositions for treating immune or inflammatory disorders or as an analgesic
Inventor: BARONI MARCO
IPC: A61K31/4418
Filed: 2002-10-14
Abstract: A compound of formula (I) is described wherein X represents N or CH; R1 represents a hydrogen or halogen atom or a CF3 group; n is an integer from 1 to 5; A represents a group of formula (a) to (d) in which m is 1 or 2; and its salts or solvates and its N-oxides. The use of the compound is disclosed to be for the preparation of analgesic medicaments and/or medicaments intended for the treatment of diseases linked to immune and inflammatory disorders.
Patent NZ-533709-A (NZ)
Title: Method for making resin bonded abrasive tools in a humid atmosphere
Inventor: SIMON MARK W
IPC: B24D7/00
Filed: 2002-12-18
Abstract: A method for producing an organically bonded abrasive article is disclosed, which comprises the steps of: (a) combining an abrasive grain component and a phenolic resin component;(b) molding the combined components; (c) thermally curing the phenolic resin component for the entire period during which the phenolic resin component polymerizes in an atmosphere comprising humidity, wherein the atmosphere has a relative humidity which exceeds normal relative humidity at a given temperature, and wherein said atmosphere contacts the molded components, thereby producing the organically bonded abrasive article. The abrasive grain optionally can first be combined with an organosilicon compound, to form organosilicon-treated abrasive grain, and then with the phenol-based resin component. In one example, the phenol-based resin is thermally cured in the presence of steam. Abrasive articles produced by the disclosed method generally have improved properties under wet grinding conditions. In one example, an abrasive article produced by this method includes ammonia in an amount less than about 50 ppm. In another example, an abrasive grinding wheel produced by this method has a percentage wet strength retention of at least about 89.9 percent.
Patent NZ-545288-A (NZ)
Title: Handheld transmission device
Inventor: JOHNSTON RICHARD LLOYD
Filed: 2006-02-10
Abstract: A handheld device that allows a user to utilise an electric fence line as a transmission line for communication with, for example, an electric fence energiser, is disclosed. The device includes an electronic communication device located within a housing (1), a conductive layer (6) electrically connected to the communication device, and a dielectric layer (7) situated on an external surface of the conductive layer. In use, the conductive layer and dielectric layer capacitively couple the communication device to a user holding the device. The handheld device does not need a separate earth probe and still protects the user from electric shock.
Patent NZ-546974-A (NZ)
Title: Gastrointestinal tract delivery systems
Inventor: AUGUSTIN MARY ANN
IPC: A23L1/30
Filed: 2004-11-22
Abstract: Provided is a method of storing storage unstable, therapeutic and nutritional agents for targeted delivery to predetermined locations in the gastrointestinal tract which includes the steps of encapsulating the storage unstable, therapeutic and nutritional agents in an encapsulant formed by combining a food grade treated carbohydrate with a water soluble food grade protein. Also provided are similar methods in which the number of sugar reducing groups in the carbohydrate is increased. Further provided is a similar method for preparing a nutritional or therapeutic product for delivery to the gastrointestinal tract.
Patent NZ-555577-A (NZ)
Title: Cutting frame for use in a curd vat comprising substantially parallel frame girders comprising a lattice of longitudinal and transverse mounted knives
Inventor: VAN DER MEULEN WIEGER
Filed: 2007-06-01
Abstract: A cutting frame for use in a curd vat (1), which cutting frame (19) comprises substantially parallel frame girders, between which is situated a lattice formed from longitudinal knives and transverse knives, of which the transverse knives are mounted on the frame girders by welding and have aligned openings, in which the longitudinal knives are received, wherein the longitudinal knives are strip-shaped knives having a length dimension and a width dimension and having at least one sharp cutting edge extending in the length dimension, which cutting edge is formed by at least one obliquely ground cutting face, wherein the width of the longitudinal knives is smaller than the corresponding dimension of the openings of the transverse knives, and wherein means are provided for substantially preventing displacement of the longitudinal knives in the length dimension, wherein at least a number of openings of at least a number of transverse knives is provided with supporting elements which substantially lock the longitudinal knives both in lateral direction and in the width dimension of the longitudinal knives, while the supporting elements leave the sharp cutting edge clear.
Patent NZ-561611-A (NZ)
Title: Container with hold-open flaps for ventilation
Inventor: VALENZUELA JUAN Z
IPC: B65D5/22
Filed: 2006-03-16
Abstract: A frozen goods packing box 10 is provided with openings 335 in the end walls and the box lid 1 is provided with corresponding openings in the end walls of the lid. The box is packed with the goods to be frozen or chilled, and the lid placed on the box, but leaving the side walls 310, 320 of the lid in the open position so that air can circulate between the interior and exterior of the lidded box through the aligned openings. Once the goods are suitably chilled, the side walls of the lid are pushed closed so that the flaps 312, 322 block off the openings in the end walls.
Patent NZ-567431-A (NZ)
Title: Blower motor with flexible support sleeve
Inventor: KENYON BARTON JOHN
IPC: A61M1/00
Filed: 2006-10-27
Abstract: A double-ended blower comprises a blower motor assembly (M) supporting opposed first (258) and second (260) shaft ends, the first (258) and second (260) shaft ends having respective first (244) and second (248) impellers attached thereto and enclosed within first (247) and second (251) volutes, respectively, wherein the first volute (247) is connected to an inlet (264) and the second volute (251) is connected to an outlet (276). The blower motor assembly (M) at least partially enclosed within a flexible sleeve (272), with a radially outer inter-stage gas path extending between the first (247) and second (251) volute, and radially inward of the flexible sleeve (272).
Patent NZ-578638-A (NZ)
Title: Tricyclic compounds and their use as glucocorticoid receptor modulators
Inventor: DEVRAJ RAJESH VENKATESWARAN
IPC: A61K31/44
Filed: 2008-01-25
Abstract: Disclosed is a tricyclic compound of Formula I or a salt thereof. Also disclosed is the use of a compound of Formula I or salt thereof in the manufacture of a medicament for treating a condition mediated by glucocorticoid receptor activity such as rheumatoid arthritis, dermatitis, asthma, Alzheimer's disease and inflammatory bowel disease.
Patent NZ-582534-A (NZ)
Title: Marking ear tag comprising a tissue sampling device
Inventor: HILPERT JEAN JACQUES
IPC: A01K11/00
Filed: 2008-06-17
Abstract: An ear tag 1 for identifying an animal, enables a sample of biological tissue to be taken when the tag is applied to the animal. The tag includes a male part 2 and a female part 3 which are assembled by irreversible interlocking between the male part on one side of the animal's ear and the female part on the other side of the ear. The stem 22 of the male part includes a detachable head 23 having a hollow distal part 29 provided with a cutting edge 25 for cutting out a biological sample when the head perforates the ear of the animal. The female part includes a central tube 31 for receiving the head and at least partially receiving the stem when the ear tag is applied, and a detachable sample container 32 arranged in the axial extension of the tube. The proximal end 35 of the container has a first opening 33 for receiving the head 23 of the stem when the ear tag is applied, and the distal end 36 of the container has a second open end 34 enabling the inside of the sample container to be reached. Once the tag is applied, the sample container with the head including the sample attached, can be removed from the tag and placed within a protection tube including a closing cover so that the sample taken can be stored in a closed space bathed in appropriate substances and analysed later.
Patent NZ-583682-A (NZ)
Title: System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts
Inventor: MENDEZ MICHAEL
IPC: C12N15/00
Filed: 2008-10-06
Abstract: A method of assembling a circular chloroplast genome by: (i) Obtaining a plurality of vectors that collectively comprise all the chloroplast genes necessary to carry out photosynthesis; (ii) Each vector comprises two regions for homologous recombination with one or two other vectors; (iii) One vector comprises a yeast DNA replication element, one vector comprises yeast selection marker and one vector comprises a yeast stability element wherein the yeast selection marker and the yeast stability element are not in the same vector; (iv) Introducing the vectors into a yeast to assemble the vectors by homologous recombination to produce a circular chloroplast genome; and (v) Selecting for the presence of the stability element. Also described is a yeast-bacteria shuttle vector that can be used for cloning of large regions of DNA by homologous recombination and can be used for isolating entire genomes of chloroplasts.
Patent NZ-584065-A (NZ)
Title: Treatment of lung cancer with scv-07
Inventor: TUTHILL CYNTHIA W
IPC: A61P35/00
Filed: 2008-08-21
Abstract: The use of an immunomodulator compound of Formula (A) for treating lung cancer and lung cancer metastasis. R is hydrogen, C2-10 acyl or C1-6 alkyl; n is 1 or 2; and X is L-tryptophan or D-tryptophan. The compound can be gamma-D-glutamyl-L-tryptophan (SCV-07).
Patent NZ-586022-A (NZ)
Title: Asphalt modifier comprising a combination of a surfactant and rheology modifier for warm-mix applications
Inventor: NAIDOO PREMNATHAN
IPC: C08K3/20
Filed: 2008-11-11
Abstract: Disclosed is an additive package for warm-mix asphalt formulations for the pavement of road surfaces, said additive package comprising (a) from 20-60 wt percent based on the total weight of the additive package of surfactant component comprising at least one surfactant selected from amines, diamines, polyamines, ethoxylated amines, ethoxylated alkyl diamines, ethoxylated alkyl polyamines, amido amines, amidopolyamines, imidazolines, and/or any of their corresponding organic and/or inorganic salts, and mixtures and combinations of same, and (b) 30-80 wt percent based on the total weight of the additive package of an asphalt rheology modifying component, wherein said asphalt rheology modifying component comprises at least one of (i) a wax component and (ii) a resin component, the additive package being formulated into a powder, pastillated or flaked free-flowing solid.
Patent NZ-594557-A (NZ)
Title: Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
Inventor: TUTINO ANTHONY
IPC: A61K9/48
Filed: 2010-05-19
Abstract: ABSTRACT - 594557 The disclosure relates to oral dosage form in the f0n11 of a capsule which comprises: (1) pomalidomide at an amount of 0.1 to 3 weight percent of the total weight of the composition; (2) a binder or filler at an amount of 90 to 99 weight percent of total weight of the composition, wherein the binder or filler is starch, mannitol or a mixture thereof. Also disclosed is an oral dosage form which weighs 62.5 mg and comprises: (1) pomalidomide, or a pharmaceutically acceptable salt or solvate thereof, at an amount that provides 0.5 mg potency of pomalidomide; (2) pregelatinized starch at an amount of 35 mg; (3) sodium stearyl fumarate at an amount of 0.16 mg; and 4) spray dried mannitol at an amount that brings the total weight of the composition to 62.5 mg. These compositions are suitable for treating, preventing or managing cancer, pain, Macular Degeneration, a skin disease, a pulmonary disorder, an asbestos related disorder, a parasitic disease, an immunodeficiency disorder, a CNS disorder, CNS injury, atherosclerosis, a sleep disorder, hemoglobinopathy, anemia, an inflammatory disease, an autoimmune disease, a viral disease, a genetic disease, an allergic disease, a bacterial disease, an ocular neovascular disease, a choroidal neovascular disease, a retina neovascular disease, or rubeosis.
Patent NZ-595402-A (NZ)
Title: Rotor with a stabilisation structure comprising a brake disc arranged at a face side
Inventor: ERIKSEN UFFE
IPC: F03D1/06
Filed: 2011-09-26
Abstract: Rotor with a stabilisation structure comprising a brake disc Rotor for a generator, comprising an axis of rotation, a circular rotor body and a circular stabilisation structure 12 arranged at a face side of the rotor body, where the stabilisation structure 12 comprises a brake disc 14 which extends radially inward from a circumferential outer portion of the stabilisation structure 12.
Patent NZ-603273-A (NZ)
Title: Vapour absorption system
Inventor: HARMAN JAYDEN
IPC: B01D53/14
Filed: 2011-04-10
Abstract: A water distillation system (11) for distilling vapour from a liquid in an evacuation chamber (14) is disclosed. The evacuation chamber (14) is evacuated via a venturi vacuum pump (16) through which an operating liquid is flowing. The vapour is condensed within the venturi throat (45) into the operating liquid. The vacuum within the evacuation chamber (14) combined with heat recovered from the latent heat of the vapour combines to cause the evaporation of more vapour. The operating fluid forms a circuit of purified water which may be withdrawn from outlet (7). The system can also be used for the distillation of ethanol.
Patent NZ-606822-A (NZ)
Title: Direct contact condenser for steam turbine
Inventor: MORIYAMA TAKASHI
IPC: F28B11/00
Filed: 2012-07-13
Abstract: Improvements to a direct contact condenser which can prevent cooling water sprayed from spray nozzles from reaching the turbine blades of an axial-flow turbine which can damage the turbine blade. Direct contact condenser consists of three major sections which are attached directly to the turbine; an exhaust gas inlet part (11); a steam cooling chamber (12); and a water storage part (13). The steam cooling chamber includes a first cooling water spraying mechanism (21) which sprays the cooling water from a perpendicular to a downstream direction which prevents water on the blades of the turbine; a second cooling water spraying mechanism (30) which sprays in all directions; and a non-condensable gas chamber.
Patent NZ-617018-A (NZ)
Title: Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
Inventor: DORFMAN ADAM R
IPC: C25C1/20
Filed: 2012-03-30
Abstract: Disclosed are gold-platinum based bi-metallic nanocrystal suspensions that have nanocrystal surfaces that are substantially free from organic or other impurities or films associated with typical chemical reductants/stabilizers and/or raw materials used in nanoparticle formation processes. Specifically, the surfaces are free of such chemical materials relative to the surfaces of metal-based nanoparticles made using chemical reduction (and other) processes that require organic (or other) reductants and/or surfactants to grow (and/or suspend) metal nanoparticles from metal ions in a solution. Disclosed are electrochemical manufacturing apparatuses and techniques for making the bi-metallic nanocrystal suspensions. The techniques do not require the use or presence of chlorine ions/atoms and/or chlorides or chlorine-based materials for the manufacturing process/final suspension. Also disclosed are pharmaceutical compositions and the use of the bi-metallic nanocrystals or suspensions or colloids thereof for the treatment or prevention of diseases or conditions for which metal-based therapy is already known, including, for example, cancerous diseases or conditions.
Patent NZ-623181-A (NZ)
Title: Compositions and methods for silencing aldehyde dehydrogenase
Inventor: MACLACHLAN IAN
IPC: C12N15/11
Filed: 2012-10-04
Abstract: Disclosed is a composition comprising an interfering RNA that silences aldehyde dehydrogenase (ALDH) gene expression, wherein the interfering RNA comprises a sense strand and a complementary antisense strand, and wherein the interfering RNA comprises a double-stranded region of about 15 to about 60 nucleotides in length, wherein the interfering RNA is selected from the group consisting of siRNA Identifiers of the sequences as defined in the specification. Also disclosed is their use in treatment.
Patent NZ-625000-A (NZ)
Title: Co-crystals of cyprodinil
Inventor: BURTON REBECCA CLAIRE
IPC: A01N25/00
Filed: 2011-04-06
Abstract: Disclosed is a co-crystal comprising cyprodinil and a co-crystal forming compound which has at least one imide functional group, wherein said co-crystal forming compound is selected from pyromellitic diimide, 2,3-naphthalenedicarboximide and phthalimide. Further disclosed is a co-crystal comprising cyprodinil and a co-crystal forming compound selected from pyromellitic diimide, 2,3-naphthalenedicarboximide and phthalimide, obtained by a process comprising a) grinding, heating or contacting in solution cyprodinil with the co-crystal forming compound, under crystallisation conditions so as to form a solid phase; and b) isolating co-crystals comprising cyprodinil and the co-crystal forming compound. Also disclosed is a fungicidal composition which comprises the co-crystal as defined above.
Patent NZ-626236-A (NZ)
Title: Integrated positive airway pressure apparatus
Inventor: LALONDE MICHAEL GERARD
IPC: A61M16/06
Filed: 2010-10-20
Abstract: A gas delivery system that provides positive airway pressure therapy is disclosed. A mask (216) couples to a patient’s face to deliver pressurized gas to an airway of the patient. The mask includes a flow generator system (220) disposed on the mask and that pressurizes the gas, the flow generator including at least one motor. A controller controls the at least one motor and may use the data from a number of sensors to modify this control. A diverter valve activated by the incoming gas blocks a unassisted breathing vent (238) in the mask. During no flow the valve blocks the inlet from the flow generator system so the patient may breath through the breathing vent. The flow generator may be detached from the mask and used with a base unit to supply gas to a second mask.
Patent NZ-627188-A (NZ)
Title: Pyrimido[4,5-b]indole derivatives and use thereof in the expansion of hematopoietic stem cells
Inventor: SAUVAGEAU GUY
IPC: A61K35/28
Filed: 2013-01-25
Abstract: Disclosed herein are pyrimido[4,5-b]indole derivatives of formulae I and II. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic stem cell populations. The compounds are also useful in the medical treatment of diseases that involve hematopoietic stem cells such as lupus, acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, myeloproliferative disorders, myelodysplastic syndromes, multiple myeloma, non-Hodgkin’s lymphoma, Hodgkin’s disease, aplastic anemia, pure red cell aplasia, hemoglobinuria, Fanconi anemia, thalassemia, sickle cell anemia, Wiskott-Aldrich syndrome, sickle cell anemia, thalassemia and Gaucher disease.
Patent NZ-629818-A (NZ)
Title: A vehicle suspension system
Inventor: MCLEAY HUGH
IPC: B62K25/12
Filed: 2013-03-01
Abstract: A driven wheel suspension system for a vehicle (100) having a chassis (12) suspended from a driven wheel (10) is disclosed. The suspension system includes a suspension mechanism including a driven wheel carrier member (11) rotatably connected to the driven wheel. The suspension mechanism is configured to isolate the movement of the driven wheel from the movement of the chassis. The driven wheel is movable a distance relative to the chassis which defines a suspension travel. The driven wheel suspension system further includes a drive train including a looped power transmission element configured to transmit power between the driven wheel and a power source mounted on the chassis. An idler member (31) is rotatably mounted on an idler carrier member (20) that is movable relative to both the chassis and driven wheel earner member. The idler member is configured to engage with a power transmitting segment (33) of the looped power transmission element and move to follow a predetermined path as a function of suspension travel, to thereby alter a path of said power transmitting segment (33) of the looped power transmission element. Altering the path of the power transmitting segment of the looped power transmission element results in a lengthening or shortening of the power transmitting segment of the looped power transmission element. The driven wheel suspension system has many applications, including but not limited to a rear wheel suspension system for a bicycle.